These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1645645)

  • 1. Comparison of Bayesian with group sequential methods for monitoring clinical trials.
    Armitage P
    Control Clin Trials; 1991 Apr; 12(2):345-50. PubMed ID: 1645645
    [No Abstract]   [Full Text] [Related]  

  • 2. Four problems with group sequential methods.
    Whitehead J
    Control Clin Trials; 1991 Apr; 12(2):340-4. PubMed ID: 1645644
    [No Abstract]   [Full Text] [Related]  

  • 3. Bayesian statistical methods in public health and medicine.
    Etzioni RD; Kadane JB
    Annu Rev Public Health; 1995; 16():23-41. PubMed ID: 7639872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A remark on 'Bayesian predictive approach to interim monitoring in clinical trials' by A. Dmitrienko and M-D. Wang.
    Cai G; Zhou T
    Stat Med; 2012 Jul; 31(16):1774-6. PubMed ID: 22729893
    [No Abstract]   [Full Text] [Related]  

  • 5. A Bayesian approach for inference from a bridging study with binary outcomes.
    Gandhi M; Mukherjee B; Biswas D
    J Biopharm Stat; 2012 Sep; 22(5):935-51. PubMed ID: 22946941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Bayesian with group sequential methods for monitoring clinical trials.
    Freedman LS; Spiegelhalter DJ
    Control Clin Trials; 1989 Dec; 10(4):357-67. PubMed ID: 2691203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian techniques for sample size determination in clinical trials: a short review.
    Pezeshk H
    Stat Methods Med Res; 2003 Dec; 12(6):489-504. PubMed ID: 14653352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-sided sequential stopping boundaries for clinical trials: a decision-theoretic approach.
    Berry DA; Ho CH
    Biometrics; 1988 Mar; 44(1):219-27. PubMed ID: 3358990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of delayed observations on Bayesian decisions for binary data.
    Williamson PP; Choi SC
    J Biopharm Stat; 1998 Nov; 8(4):599-617. PubMed ID: 9855037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
    Lewis RJ; Lipsky AM; Berry DA
    Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian designs and the control of frequentist characteristics: a practical solution.
    Ventz S; Trippa L
    Biometrics; 2015 Mar; 71(1):218-226. PubMed ID: 25196832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian interim analysis in clinical trials.
    Zhang X; Cutter G
    Contemp Clin Trials; 2008 Sep; 29(5):751-5. PubMed ID: 18589003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian predictive approach to interim monitoring in clinical trials.
    Dmitrienko A; Wang MD
    Stat Med; 2006 Jul; 25(13):2178-95. PubMed ID: 16007570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The what, why and how of Bayesian clinical trials monitoring.
    Freedman LS; Spiegelhalter DJ; Parmar MK
    Stat Med; 1994 Jul 15-30; 13(13-14):1371-83; discussion 1385-9. PubMed ID: 7973217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Robustness considerations in Bayesian analysis.
    Gustafson P
    Stat Methods Med Res; 1996 Dec; 5(4):357-73. PubMed ID: 9004378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Phases 0, 1 and 2 oncology clinical trials: current questions].
    Penel N; Fournier C; Stéphanie C
    Bull Cancer; 2010 Jan; 97(1):55-63. PubMed ID: 20080458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interim analysis in clinical trials.
    Armitage P
    Stat Med; 1991 Jun; 10(6):925-35; discussion 936-7. PubMed ID: 1876782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practical aspects in data monitoring: a brief review.
    Demets DL
    Stat Med; 1987; 6(7):753-60. PubMed ID: 3321314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian approach to noninferiority trials for proportions.
    Gamalo MA; Wu R; Tiwari RC
    J Biopharm Stat; 2011 Sep; 21(5):902-19. PubMed ID: 21830922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A practical guide to Bayesian group sequential designs.
    Gsponer T; Gerber F; Bornkamp B; Ohlssen D; Vandemeulebroecke M; Schmidli H
    Pharm Stat; 2014; 13(1):71-80. PubMed ID: 24038922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.